Terkko Navigator / Journal of Oncology Pharmacy Practice

Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team

Does equipment change impact blood contamination with irinotecan and its two major metabolites in a centralized cytotoxic pharmacy unit?

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol

5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine

Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents

Intravenous lidocaine affects oxaliplatin pharmacokinetics in simultaneous infusion

The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience

Quantification of healthcare workers’ exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study

Development and implementation of an electrolyte replacement protocol in the outpatient oncology infusion centers of a large academic healthcare system

Expansion of pharmacist practice in oral oncolytic therapy with a collaborative practice agreement

Stability studies of parenteral nutrition with a high dose of vitamin C

Managing chemotherapy-related toxicities in the community setting: A survey of pharmacists in Ontario

Toxicity profile of Doxorubicin-Cyclophosphamide and Doxorubicin-Cyclophosphamide followed by Paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: A prospective cohort study

Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results

Application of KW-ANOVA statistics to generate evidence for cytotoxic drug wastage induced financial burden among cancer patients: A clinical pharmacist observation

Intraperitoneal paclitaxel and cisplatin compared with dose-dense paclitaxel and carboplatin for patients with stage III ovarian cancer

Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

Evaluation of mobilization efficacy with an extended interval following plerixafor administration

Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis

The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy

Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective study

Centralization impact and cost-saving study in a Moroccan hospital’s centralized unit of chemotherapy preparation

Prospective evaluation of drug–drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation

Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin

Evaluation of the efficacy and safety of apixaban and rivaroxaban in cancer patients receiving concomitant active anti-neoplastic therapy at an outpatient cancer setting

The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort

Effectiveness of a pharmaceutical instruction video for adherence to dermatopathy treatment in patients with cancer receiving the anti-epidermal growth factor receptor antibody

Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Off-label infusion of biosimilar bevacizumab: A provincial experience

Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center

Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura

Management of skin adverse reactions in oncology

Continuous-infusion and outpatient setting: A chance for patients, a challenge for hospital pharmacists

Optimizing care for high-risk neuroblastoma patients treated with dinutuximab: Challenges for the multidisciplinary team

The pharmacist’s role in chimeric antigen receptor T cell therapy

Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic

Bruton’s tyrosine kinase inhibitors and the kidney: Focus on ibrutinib

Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis

Advantages of everolimus therapeutic drug monitoring in oncology when drug–drug interaction is suspected: A case report

Chemotherapy-induced pneumonitis associated with transient CA 15-3 elevation

Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAFV600E-mutant metastatic melanoma

Real-time comprehensive toxicology testing in the clinical management of accidental pediatric capecitabine ingestion

Sweet’s syndrome under ipilimumab therapy and a brief comparison of the cases in literature

Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma

Saddle pulmonary embolism with fluorouracil: A case report

Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction

Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report

Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature

Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia